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Background: Machine learning models have shown high performance,
particularly in the diagnosis and prognosis of oral cancer. However, in actual
everyday clinical practice, the diagnosis and prognosis using these models remain
limited. This is due to the fact that these models have raised several ethical and
morally laden dilemmas. Purpose: This study aims to provide a systematic state-
of-the-art review of the ethical and social implications of machine learning
models in oral cancer management. Methods: We searched the OvidMedline,
PubMed, Scopus, Web of Science and Institute of Electrical and Electronics
Engineers databases for articles examining the ethical issues of machine learning
or artificial intelligence in medicine, healthcare or care providers. The Preferred
Reporting Items for Systematic Review and Meta-Analysis was used in the
searching and screening processes. Findings: A total of 33 studies examined the
ethical challenges of machine learning models or artificial intelligence in
medicine, healthcare or diagnostic analytics. Some ethical concerns were data
privacy and confidentiality, peer disagreement (contradictory diagnostic or
prognostic opinion between the model and the clinician), patient’s liberty to
decide the type of treatment to follow may be violated, patients–clinicians’
relationship may change and the need for ethical and legal frameworks.
Conclusion: Government, ethicists, clinicians, legal experts, patients’
representatives, data scientists and machine learning experts need to be involved
in the development of internationally standardised and structured ethical review
guidelines for the machine learning model to be beneficial in daily clinical
practice.
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1 Introduction
Cancer is the second leading cause of death, with an estimated 9.6 million deaths
worldwide in 2018 (Bray et al., 2018). From this estimation, oral cancer accounts for
354,864 new cases and 177,384 deaths (Bray et al., 2018), making it one of the most
common cancers and thus a source of significant health concern. Notably, oral
squamous cell carcinoma is the most frequent of all cases of oral cancer (Ng et al.,
2017). It represents about 90% of all the reported cases of oral cancer (Le Campion et
al., 2017; Neville et al., 2009). Oral tongue cancer has been reported to have a worse
prognosis than squamous cell carcinoma arising from other subsites of the oral cavity
(Rusthoven et al., 2008). Therefore, an accurate tool for the effective prognostication
of oral cancer is necessary.
Artificial intelligence (AI), or its subfield machine learning (ML), holds great
promise in effective oral cancer diagnosis and prognosis (Amato et al., 2013), clinical
decision making (Bennett & Hauser, 2013; Esteva et al., 2019; Topol, 2019) and
personalised medicine (Dilsizian & Siegel, 2014) because of the improved availability
of large datasets (big data), increased computational power and advances in ML
training algorithms. In the era of unprecedented technological advancements, AI or ML
is recognised as one of the most important application areas. It is currently positioned
at the apex of the hype curve and is touted to facilitate improved diagnostics,
prognostics, workflow and treatment planning and monitoring of oral cancer patients.
Several studies have been published emphasising the importance of ML
techniques in prediction outcomes, such as recurrence (Alabi, Elmusrati, Sawazaki-
Calone, et al., 2019; Alabi, Elmusrati, Sawazaki‐Calone, et al., 2019), occult node
metastasis (Bur et al., 2019) or five-year overall survival in oral cancer patients
(Karadaghy et al., 2019). Despite the reported high accuracy in the application of ML
techniques in head and neck cancer studies, there is also some trepidation among
clinicians regarding its uncertain effect on the demand and training of the current and
future workforce. Some clinicians have considered the introduction of ML to daily
routine medical practice as a transformative improvement in the ability to diagnose the
disease early enough and more accurately, and others have expressed concerns about
the assessment of and consensus on possible ethical pitfalls. Interestingly, this is usually
the case with most disruptive technologies.
The adoption of AI technology in actual daily medical practice has been
argued to threaten patients’ preference, safety and privacy (Michael, 2019).
Considering the progress made by AI technology and ML-based models in cancer
management, the current policy and ethical guidelines are lagging (Michael, 2019).
Although there are some efforts to engage in these ethical discussions (Luxton, 2014,
2016; Peek et al., 2015), the medical community needs to be informed about the
complexities surrounding the application of AI technology and ML-based models in
actual clinical practice (Michael, 2019).
Studies have examined the ethical challenges in the implementation of AI, or
its subfield ML, in healthcare or medicine. As this approach seems general, few
published works have focused on the ethical challenges in AI or ML in oral cancer.
Therefore, our study aims to systematically review the research on the ethics of AI in
medicine. This study mainly focuses on ML models. These ethical dilemmas are
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adapted to when these ML models are used in oral cancer management. To this end,
this systematic review addresses the following research questions (RQ):
RQ. What are the ethical challenges in the integration of the ML model into
the daily clinical practice of oral cancer management?
RQ. What are the generic approaches to addressing these ethical challenges?
This paper is organised as follows. Section 2 describes the methodology. Section 3
examines the results obtained from the systematic review. Section 4 discusses the
results and the implications for daily clinical practices.
2 Materials and methods
2.1 Search protocol
In this study, we systematically retrieved all studies that examined ethics in ML or AI.
The systematic search included the databases of OvidMedline, PubMed, Scopus,
Institute of Electrical and Electronics Engineers, Web of Science and Cochrane Library
from their inception until 17 March 2020. The search approach was developed by
combining the following search keywords: [(‘machine learning OR artificial
intelligence’) AND (‘ethics’)]. The retrieved hits were further analysed for possible
duplicates and irrelevant studies. To further minimise the omission of any study, the
reference lists of all eligible articles were manually searched to ensure that all the
relevant studies were duly included. In addition, the Preferred Reporting Items for
Systematic Review and Meta-Analysis was used in the searching and screening
processes (Figure 1).
Figure 1. The number of articles included that examined the ethical concerns of ML models
in medicine.
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2.2 Inclusion and exclusion criteria
All original articles that considered the ethics of ML or AI in medicine or healthcare
were included in this study. The eligible studies must have evaluated the ethical
considerations or concerns of ML or AI in medicine. Studies that examined privacy
issues, ethics of data practice and stewardship were also deemed eligible. Owing to the
nature of the research questions in this study, perspectives, editorials and reviews were
included. However, studies on animals, abstracts and conference papers were omitted.
Articles in languages other than English were also excluded (Figure 1).
2.3 Screening
A data extraction sheet was used to minimise errors due to the omission of eligible
studies.
2.4 Data extraction
The extracted parameters from each study included the author’s/authors’ name, year of
publication, country of authors, title of studies and summary of the ethical issues
mentioned in the study (Supplementary Table 1). Other important parameters, such as
how to address such ethical challenges, were noted and discussed collectively in the
discussion section.
3 Results
3.1 Results of the search strategy
The flow chart (Figure 1) describes the study selection process. A total of 931 hits were
retrieved. Among them, 178 studies were found to be duplicate studies, and 591 were
found to be irrelevant to the research questions in this review. Additionally, 129 studies
did not consider ethics in medicine, biomedicine, healthcare, predictive analytics,
digital health or patients. Thus, they were all excluded. Overall, 33 studies were found
eligible for this systematic review (Figure 1, Supplementary Table 1). The findings of
these studies indicated the ethical consideration of AI or ML in medicine. They were
examined on how they relate to the implementation of ML models in oral cancer
management. The ethical concerns discussed in these studies were privacy and
confidentiality of patients’ data, bias in the data used to develop the model, peer
disagreement (Grote & Berens, 2020), responsibility or accountability gap (Grote &
Berens, 2020; Jaremko et al., 2019; Kwiatkowski, 2018), fiduciary relationship
between physicians and patients may change (Char et al., 2018; Nabi, 2018; Reddy et
al., 2020) and patients’ autonomy may be violated (Arambula & Bur, 2020; Boers et
al., 2020; Grote & Berens, 2020; Johnson, 2019). These ethical concerns, brief
definitions and corresponding structural aspects (what and how to address these
concerns) are presented in Table 1.
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Table 1. Ethical concerns of ML models in oral cancer prognostication.
Ethical
concerns
Meaning The structural aspect of the ethical concerns









Concern 1: Will the ML





Concern VII: How can the developer
seek informed consent from the
patient, hospital authority and
national agency?










Concern II: Will the
developed ML model be
biased due to the
imbalance in the data?
Concern VIII: How can the
developer handle the possible data









Concern III: Will the
clinician follow his/her
own diagnostic decision
in cases in which the ML
model gives a contrary
opinion?
Concern IX: How can I find balance
between conflicting diagnostic
opinions? Is there an ethical
guideline or standard that guides the









Concern IV: Will the
clinician be held
responsible when the ML
model gives a wrong
prediction?
Concern X: How should the
clinicians interpret the hospital
guidelines on the use of ML models?
What does medical ethics stipulate?
What are ethical guidelines or
standards that guide the use of ML










Concern V: Will the
patient feel comfortable
and confident about the
diagnostic decision made
by a machine/computer?
Concern X1: How will I explain to
the patient that the ML model is
capable of making an accurate
decision? How can I further justify
the decision made by the model?








part in a shared
decision-making
process
Concern VI: Will the
patient be allowed to
choose the treatment
approach that suits
him/her when the model
gives a different
treatment plan?
Concern XII: How can the clinician
take into consideration the treatment
plan that best considers the daily
activities of the patient?
The title of each concern (Table 1) addresses the core ethical challenge: in the case of
ethical and moral concerns, ‘Will the clinician, ML developer or the corresponding
model perform the unethical action?’ and in the case of morally acceptable actions,
‘How can the clinician, ML developer or the corresponding model resolve the ethical
concerns’? From these findings, it is important for the ML model to be trustworthy
before it can be considered in actual medical practice. To ensure the trustworthiness of
the model, the five trustworthiness principles of transparency, credibility, auditability,
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reliability and recoverability should be incorporated (Figure 2) (Keskinbora, 2019;
Rossi, 2016). Moreover, an ethics board has been proposed to discuss ethics in ML
models from the perspective of experts and patients (Mamzer et al., 2017) (Figure 3).
3.2 Characteristics of the study
In terms of language, all the studies included were conducted in English. Out of the 33
included studies, 16 (48.5%) emphasised the privacy and confidentiality of patients’
data (Bali et al., 2019a; Balthazar et al., 2018; Boers et al., 2020; Geis et al., 2019;
Grote & Berens, 2020; Jaremko et al., 2019; Kluge, 1999; Kohli & Geis, 2018; Ma et
al., 2019; Nabi, 2018; Nebeker et al., 2019; Reddy et al., 2020; Seddon, 1996; Sethi &
Theodos, 2009; Vayena et al., 2018; Yuste et al., 2017), 13 (39.4%) examined the
significance of informed consent, data protection, access, usability, sharing and
regulatory schemes or rules prior to the use of patients’ data (Balthazar et al., 2018;
Gruson et al., 2019; Jaremko et al., 2019; Kluge, 1999; Kohli & Geis, 2018, 2018; Ma
et al., 2019; Nabi, 2018; Nebeker et al., 2019; Reddy et al., 2020; Sethi & Theodos,
2009; Vayena et al., 2018; Yuste et al., 2017), 12 (36.4%) discussed the possibility bias
in the data used for ML applications (Boers et al., 2020; Cahan et al., 2019; Char et al.,
2018; Geis et al., 2019; Grote & Berens, 2020; Gruson et al., 2019; Kohli & Geis, 2018;
Nabi, 2018; Reddy et al., 2020; Vayena et al., 2018; Wiens et al., 2019; Yuste et al.,
2017), 4 (12.1%) suggested that the integration of ML models in clinical settings could
assist clinicians to make informed decisions (Berner, 2002; Boers et al., 2020; Grote &
Berens, 2020; Kwiatkowski, 2018) and 13 (39.4%) reported the need for ethical
principles, guidelines and legal frameworks before ML models could be integrated into
medical practice (Arambula & Bur, 2020; Cahan et al., 2019; Char et al., 2018; Gruson
et al., 2019; Jian, 2019; Johnson, 2019; Keskinbora, 2019; Mamzer et al., 2017; Morley
& Floridi, 2020; Nebeker et al., 2019; Rajkomar et al., 2018; Reddy et al., 2020; Robles
Carrillo, 2020).
4 Discussion
This systematic review examined the ethical challenges in ML models in clinical
practice. These challenges were examined on how they relate to the integration of ML
models in oral cancer management. These ethical challenges carry significant
implications in terms of integrating the ML model for daily routine in oral cancer
management. The following highlights these ethical challenges and suggests a generic
approach to addressing them.
Data privacy and confidentiality: the patient’s consent should be sought
The first of these ethical concerns is healthcare data privacy (Arambula & Bur,
2020; Nabi, 2018). Developing ML models involves the substantial usage of healthcare
data of patients. Therefore, it raises privacy and patient confidentiality concerns (Ma et
al., 2019; Nabi, 2018). To arrest this concern, the patients, or their respective subjects,
need to be informed about the collection and usage of their data (Geis et al., 2019;
Powles & Hodson, 2017) to ensure informed consent and avoid illegal proprietary
exploitation of the data and data privacy breaches (Bali et al., 2019b; Balthazar et al.,
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2018; Char et al., 2018; Nabi, 2018; Powles & Hodson, 2017; Yuste et al., 2017).
Nevertheless, it is important that data use agreements should be reviewed and approved
by the appropriate quarters (Kohli & Geis, 2018). Moreover, a scheme (i.e., privacy-
preserving clinical decision with cloud support) that preserves the privacy of the patient
in terms of their data can be introduced (Geis et al., 2019; Liu et al., 2017; Ma et al.,
2019; Vayena et al., 2018; Wang et al., 2015; Zhang et al., 2018). However, the
discussion about the ownership of the data is beyond the scope of this study.
Trustworthy AI: the model should be trustworthy
It is important for the model to work as expected. Therefore, the model should
have minimal errors in the training phase. Any form of error/malfunctioning of the
model should be mentioned and defined (England & Cheng, 2019; Park & Kressel,
2018; Vayena et al., 2018; Zou & Schiebinger, 2018) to give transparency to the model
and consequently, the results from these models (Geis et al., 2019; Park et al., 2019).
Therefore, a possible imbalance in the data should be considered when developing the
model to ensure the trustworthiness of the model. To address this challenge, related
guidelines can be followed for transparent reporting (Bossuyt et al., 2015; Collins et
al., 2015; England & Cheng, 2019). With these guidelines, the ML model deployed will
be trustworthy and uphold the fundamental pillars of medical ethics (autonomy,
beneficence, nonmaleficence and justice) (Arambula & Bur, 2020) and the ethical
principles of transparency, credibility, audibility, reliability and recoverability
(Keskinbora, 2019) (Figure 2).
Figure 2. The trustworthiness principles expected from a ML model
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In this way, an inherently biased model is avoided (Arambula & Bur, 2020; Collins &
Moon, 2018; Reddy et al., 2020; Wiens et al., 2019). Trustworthiness should not only
concern the properties of the ML or AI inherent model but also the socio-technical
systems involving the ML or AI applications (European Commission, 2019), that is,
the expected trustworthiness of all actors and processes that constitute the socio-
technical context in the application of AI for the prognostication of oral tongue cancer.
Thus, for trustworthiness in AI, the essential components of trust in design,
development, law compliance, ethics and robustness must be present (European
Commission, 2019). In addition, the key requirements for a trustworthy AI include
human regulatory agency, technical robustness and safety, privacy and data
governance, transparency, non-discrimination and fairness, environmental friendliness
and compliance, and accountability (European Commission, 2019).
Peer disagreement: the model and clinician should act to protect the patient from harm
As the ML model is viewed as an expert system/model, peer disagreement and
its possible resolution guidelines are another important ethical issue (Christensen, 2007;
Kelly T, 2010). What happens when the model and the clinicians disagree on the output
of a proposition (diagnosis or prognosis) (Frances & Matheson, 2018)? It is impossible
to have a dialogical engagement with the model, as proposed by Mercier and Sperber
in the argumentative theory of reasoning (Mercier & Sperber, 2017). Should the
clinician follow the proposition of the ML model (Christensen, 2007) or adhere to her
own proposition (Enoch, 2010)? Therefore, there is a standoff in terms of the possible
decision to make by the clinician. In this case, ethical guidelines and legal frameworks
become imperative (Figure 3).
Figure 3. Ethical and legal frameworks for ethical agreements.
The ethical guidelines in this case ensure that clinicians make a decision to protect the
safety and improve the overall health condition of the patient. The hospital and ethical
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guidelines should also address the possible errors that may arise from using the model
(responsibility gap).
Patients’ autonomy: shared decision making
The ethical question of patients’ autonomy also comes to fore (Grote & Berens, 2020).
For example, an ML model that predicts the type of treatment for an oral cancer patient
should eschew the preferred treatment that could minimise the suffering of the patient.
Instead, it should maximise the lifespan and overall survival of the patient, thereby
making this model paternalistic in nature. This raises the ethical question of a shared
decision making between the clinician and the patient to ensure that the autonomy and
dignity of the patient are not violated (McDougall, 2019). Therefore, it is important to
establish relevant standards to determine which information from the ML model is
essential to be explained to the patient to be regarded as informed consent so that the
patient can make an informed decision (Grote & Berens, 2020; McDougall, 2019;
Mittelstadt & Floridi, 2016).
Humanness: Empathy and trust from the clinician–patient relationship
Another ethical concern is the ‘humanness’ of clinicians and the role of
cognitive empathy, trust, responsibility and confidentiality among clinicians (Boers et
al., 2020). This seems to be a source of concern, as the integration of ML models in
oral cancer management may lead to a paradigm shift from the current face-to-face or
direct interaction between patients and clinicians (two-way diagnostic procedure) to a
triangular relationship of patients–models–clinicians (three-way diagnostic procedure).
This concern becomes pronounced especially when the models are publicly available,
as the patients may engage in self-medication and self-management. Thus, the
fundamental aspects of patients’ care may be undermined (Boers et al., 2020). To
mitigate this, these models should be integrated in such a way that restricts patients’
access. In this way, the patient–clinician relationship can still be maintained, as this
type of relationship has been reported to influence how patients respond to their
illnesses and treatments (Kelley et al., 2014).
Ethics is one of the essential components to achieve a trustworthy AI. It is
important to have a model that ensures compliance to ethical norms and principles,
including fundamental human rights, moral entitlements and acceptable moral values
(European Commission, 2019). As mentioned previously, some of these principles
include respect for human autonomy, prevention of harm, fairness and explicability
(European Commission, 2019). To this end, we tend to agree with the suggestion of
setting up a dedicated ethical research agenda (Boers et al., 2020). This ethical research
agenda is expected to form the required premise for the development of internationally
standardised and structured ethical review guidelines (Arambula & Bur, 2020; Gruson
et al., 2019; Johnson, 2019, 2019). These guidelines should emphasise the fundamental
ethical rules of honesty, truthfulness, transparency, benevolence, non-malevolence and
respect for autonomy (Keskinbora, 2019) and address other criticisms surrounding the
application of ML-based models in actual clinical practice (Figure 4).
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Figure 4. The fundamental ethical principles expected from the clinician and the ML model.
Aside from these ethical guidelines, corresponding laws (internal framework and
international sphere) should be enacted by the government to ensure the legal (e.g., the
European General Data Protection Regulations) (Flaumenhaft & Ben-Assuli, 2018;
Vayena et al., 2018) and jurisdictional mechanisms for their enforcement (Robles
Carrillo, 2020).
In conclusion, the development of ML models should take the ethical and legal
framework into consideration from the data collection to the ML process and to the
integration into clinical practice. A strong and proactive role is expected from the
government, clinical experts, patients’ representatives, data scientists, ML experts and
legal and human rights activists in defining these ethical guidelines. Through this, ML
models can achieve the touted benefits of optimising health systems and decision
support for professionals and improve the overall health of patients. As oral tongue
cancer was considered in this study, the ethical concerns mentioned and the proposed
solution are peculiar to other cancer types.
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Appendix
Supplementary Table 1. Included studies and the main ethical points discussed (below)
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